Kalaris Therapeutics, Inc.
KLRS
$3.41
-$0.06-1.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 93.54M | 97.22M | 117.98M | 77.00M | 88.43M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.87M | 861.00K | 827.00K | 1.18M | 3.23M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 514.00K | 389.00K | -- | -- | -- |
| Total Current Assets | 95.92M | 98.47M | 118.81M | 78.18M | 91.65M |
|
|
|||||
| Total Current Assets | 95.92M | 98.47M | 118.81M | 78.18M | 91.65M |
| Net Property, Plant & Equipment | 1.39M | 1.43M | 1.48M | 1.52M | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.23M | 2.25M | 1.45M | 1.48M | 1.19M |
| Total Assets | 99.54M | 109.81M | 121.74M | 81.18M | 92.84M |
|
|
|||||
| Total Accounts Payable | 1.12M | 905.00K | 1.28M | 494.00K | 3.68M |
| Total Accrued Expenses | 7.27M | 6.86M | 8.12M | 5.20M | 3.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 347.00K | 317.00K | 316.00K | 376.00K | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.74M | 8.08M | 9.71M | 6.07M | 7.65M |
|
|
|||||
| Total Current Liabilities | 8.74M | 8.08M | 9.71M | 6.07M | 7.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.05M | 1.09M | 1.13M | 1.17M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 32.08M | 32.08M | 32.08M | 32.08M | 32.08M |
| Total Liabilities | 41.87M | 41.25M | 42.92M | 39.31M | 39.73M |
|
|
|||||
| Common Stock & APIC | 240.12M | 239.46M | 238.81M | 191.86M | 191.22M |
| Retained Earnings | -182.37M | -170.86M | -160.00M | -150.00M | -138.11M |
| Treasury Stock & Other | -73.00K | -49.00K | 6.00K | 6.00K | -- |
| Total Common Equity | 57.67M | 68.56M | 78.81M | 41.87M | 53.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 57.67M | 68.56M | 78.81M | 41.87M | 53.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 57.67M | 68.56M | 78.81M | 41.87M | 53.12M |
|
|
|||||